The Board of Directors of Procter & Gamble Health Limited at its meeting held on February 5, 2023, recommended an interim dividend of INR 45 per Equity Share (Face Value of INR 10 each) for the Financial Year 2022-23. The dividend shall be paid on or before March 05, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,749 INR | +0.90% | -0.14% | -3.98% |
03/05 | Procter & Gamble Health's Profit Declines in Fiscal Q3 | MT |
02/05 | Procter & Gamble Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.98% | 94Cr | |
+22.69% | 4.38TCr | |
+25.56% | 2.3TCr | |
+18.96% | 1.53TCr | |
+8.91% | 1.37TCr | |
+42.72% | 1.2TCr | |
-7.49% | 697.64Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+13.26% | 559.02Cr |
- Stock Market
- Equities
- PGHL Stock
- News Procter & Gamble Health Limited
- Procter & Gamble Health Limited Recommends an Interim Dividend for the Financial Year 2022-23, Payable on or Before March 05, 2023